extract: 2025-03-17-norc-pace-market-assessment-for-profit-expansion

Pentagon-Agent: Ganymede <F99EBFA6-547B-4096-BEEA-1D59C3E4028A>
This commit is contained in:
Teleo Agents 2026-03-15 19:04:10 +00:00
parent d378ee8721
commit 87fdc3070c
5 changed files with 76 additions and 1 deletions

View file

@ -38,6 +38,12 @@ Some evidence indicates lower mortality rates among PACE enrollees, suggesting q
Japan's LTCI provides a national-scale comparison point for PACE's integrated care model. LTCI offers both facility-based and home-based care chosen by beneficiaries, integrating medical care with welfare services across 7 care level tiers. As of 2015, the system served 5+ million beneficiaries (17% of 65+ population) — compared to PACE's 90,000 enrollees in the US. If the US had equivalent coverage, that would represent ~11.4 million people. Japan's experience demonstrates that integrated care delivery can operate at national scale through mandatory insurance, though financial sustainability under extreme aging demographics (28.4% elderly, rising to 40%) remains an ongoing challenge requiring premium and copayment adjustments.
### Additional Evidence (extend)
*Source: [[2025-03-17-norc-pace-market-assessment-for-profit-expansion]] | Added: 2026-03-15*
NORC 2025 report confirms PACE serves average age 76, 7+ chronic conditions, nursing-home eligible population—the most complex, costly Medicare-Medicaid beneficiaries. This is the population MA plans are least equipped to serve profitably, making PACE the existence proof that full capitation works for high-complexity cases. The 12% annual growth in 2025 (reaching 90,580 enrollees) is faster than recent years, suggesting potential inflection despite 50-year 0.13% penetration rate.
---
Relevant Notes:

View file

@ -291,6 +291,12 @@ PACE provides the most comprehensive real-world test of the prevention-first att
The Commonwealth Fund's 2024 international comparison provides evidence that the prevention-first attractor state is not theoretical — peer nations demonstrate it empirically. The top performers (Australia, Netherlands) achieve better health outcomes with lower spending as percentage of GDP, suggesting their systems have structural features that prevent rather than treat. The US paradox (2nd in care process, last in outcomes, highest spending, lowest efficiency) reveals a system optimized for treating sickness rather than producing health. The efficiency domain rankings (US among worst — highest spending, lowest return) quantify the cost of a sick-care attractor state. The international benchmark shows that systems with better access, equity, and prevention orientation achieve superior outcomes at lower cost, suggesting the prevention-first attractor state is achievable and economically superior to the current US sick-care model.
### Additional Evidence (challenge)
*Source: [[2025-03-17-norc-pace-market-assessment-for-profit-expansion]] | Added: 2026-03-15*
PACE represents the attractor state's core elements (full capitation, integrated care, single provider-payer) but has achieved only 0.13% Medicare penetration after 50 years. Seven structural barriers prevent scaling: capital requirements, awareness deficits, insufficient enrollee concentration, geographic concentration, financial eligibility barriers, regulatory complexity, and single-state operator limitations. This suggests the attractor state may be theoretically correct but practically unreachable under current conditions—the gap between model elegance and market reality is enormous.
---
Relevant Notes:

View file

@ -29,6 +29,12 @@ PACE represents the extreme end of value-based care alignment—100% capitation
GLP-1 persistence data illustrates why value-based care requires risk alignment: with only 32.3% of non-diabetic obesity patients remaining on GLP-1s at one year (15% at two years), the downstream savings that justify the upfront drug cost never materialize for 85% of patients. Under fee-for-service, the pharmacy benefit pays the cost but doesn't capture the avoided hospitalizations. Under partial risk (upside-only), providers have no incentive to invest in adherence support because they don't bear the cost of discontinuation. Only under full risk (capitation) does the entity paying for the drug also capture the downstream savings—but only if adherence is sustained. This makes GLP-1 economics a test case for whether value-based care can solve the "who pays vs. who benefits" misalignment.
### Additional Evidence (confirm)
*Source: [[2025-03-17-norc-pace-market-assessment-for-profit-expansion]] | Added: 2026-03-15*
PACE is the most fully integrated capitated model in existence—100% of member's medical, social, and psychiatric needs under single provider-payer, entirely replacing Medicare and Medicaid cards. Yet after 50 years it serves only 90K of 67M Medicare-eligible (0.13% penetration). This confirms that even proven full-risk models face structural barriers to scaling, supporting the claim that VBC stalls at the payment boundary despite model success.
---
Relevant Notes:

View file

@ -0,0 +1,40 @@
{
"rejected_claims": [
{
"filename": "pace-50-year-failure-to-scale-proves-structural-barriers-prevent-full-capitation-despite-model-success.md",
"issues": [
"missing_attribution_extractor"
]
},
{
"filename": "for-profit-pace-entry-creates-scaling-inflection-through-capital-and-operational-capacity-but-risks-mission-drift.md",
"issues": [
"missing_attribution_extractor"
]
},
{
"filename": "pace-market-concentration-in-three-states-prevents-national-model-validation-and-limits-policy-generalization.md",
"issues": [
"missing_attribution_extractor"
]
}
],
"validation_stats": {
"total": 3,
"kept": 0,
"fixed": 3,
"rejected": 3,
"fixes_applied": [
"pace-50-year-failure-to-scale-proves-structural-barriers-prevent-full-capitation-despite-model-success.md:set_created:2026-03-15",
"for-profit-pace-entry-creates-scaling-inflection-through-capital-and-operational-capacity-but-risks-mission-drift.md:set_created:2026-03-15",
"pace-market-concentration-in-three-states-prevents-national-model-validation-and-limits-policy-generalization.md:set_created:2026-03-15"
],
"rejections": [
"pace-50-year-failure-to-scale-proves-structural-barriers-prevent-full-capitation-despite-model-success.md:missing_attribution_extractor",
"for-profit-pace-entry-creates-scaling-inflection-through-capital-and-operational-capacity-but-risks-mission-drift.md:missing_attribution_extractor",
"pace-market-concentration-in-three-states-prevents-national-model-validation-and-limits-policy-generalization.md:missing_attribution_extractor"
]
},
"model": "anthropic/claude-sonnet-4.5",
"date": "2026-03-15"
}

View file

@ -7,9 +7,13 @@ date: 2025-03-17
domain: health
secondary_domains: []
format: report
status: unprocessed
status: enrichment
priority: high
tags: [pace, all-inclusive-care, elderly, capitated-care, scaling-barriers, for-profit, integrated-care]
processed_by: vida
processed_date: 2026-03-15
enrichments_applied: ["pace-demonstrates-integrated-care-averts-institutionalization-through-community-based-delivery-not-cost-reduction.md", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md"]
extraction_model: "anthropic/claude-sonnet-4.5"
---
## Content
@ -69,3 +73,16 @@ tags: [pace, all-inclusive-care, elderly, capitated-care, scaling-barriers, for-
PRIMARY CONNECTION: [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
WHY ARCHIVED: PACE is the strongest counter-evidence and supporting evidence simultaneously — it proves the model works AND that structural barriers prevent scaling. Essential for honest distance measurement.
EXTRACTION HINT: The 0.13% penetration after 50 years is the key number. Compare to MA's 54% — what does the gap reveal about what actually scales in US healthcare?
## Key Facts
- PACE enrolled 80,815 participants on January 1, 2025, growing to 90,580 by year-end (12% annual growth)
- 198 PACE programs operate in 33 states plus DC as of 2025
- Over 376 PACE centers serve approximately 87,000 participants (September 2025 data)
- Nearly half of all PACE enrollees served by 10 largest parent organizations
- Only 13 states have 1,000+ PACE enrollees
- Over half of PACE enrollees concentrated in California, New York, and Pennsylvania
- Average PACE member: 76 years old, 7+ chronic conditions, nursing-home eligible
- PACE has operated since the 1970s (On Lok in San Francisco)
- PACE serves 0.13% of 67M Medicare-eligible population
- Most PACE parent organizations operate single program in one state